Literature DB >> 17488391

Assessing exercise performance after heart transplantation.

Gaye Ulubay1, Sevinc Sarinc Ulasli, Atilla Sezgin, Mehmet Haberal.   

Abstract

OBJECTIVE: Heart transplantation improves the survival rate and quality of life in patients with severe symptoms of congestive heart failure and an ejection fraction of 20% or less. Despite marked symptomatic and clinical improvement in those who undergo heart transplantation, exercise capacity often remains reduced, and the factors limiting exercise performance during the post-transplantation period remain unclear. This study was performed to investigate the factors affecting exercise capacity in heart transplantation recipients. PATIENTS AND METHODS: Fourteen patients with cardiomyopathy were enrolled in this study. We measured peak exercise oxygen uptake (peak VO(2)) in seven patients (age range: 42 +/- 14 yr) 10-28 months after transplantation, in seven patients (age range: 33 +/- 18 yr) with dilated cardiomyopathy before heart transplantation, and in 14 healthy control subjects (age range: 44 +/- 12 yr). The left ventricular ejection fraction, Beck Depression Inventory score, Medical Outcome Health Survey Short Form-36 Questionnaire (SF-36) results, and immunosuppressive therapy administered were recorded in all patient groups.
RESULTS: All patients in the post-transplantation group terminated exercise testing before the anaerobic threshold because of general fatigue. All heart transplantation recipients exhibited a left ventricular ejection fraction within the normal range (mean +/- SD = 57% +/- 2%). The peak VO(2) mean values were significantly different among the three groups (p = 0.001). There were statistically significant correlations between the peak VO(2) values and the Beck Depression Inventory scores (r = -0.637, p = 0.01), between the peak VO(2) values and bodily pain (r = 0.717, p = 0.006), between the peak VO(2) values and general health perceptions (r = 0.706, p = 0.007), and between peak VO(2) values and postoperative duration (r = 0.843, p = 0.03) in all patient groups.
CONCLUSION: In the long-term treatment of heart transplant recipients, exercise training should be considered an important therapeutic tool that enables patients to achieve a good quality of life.

Entities:  

Mesh:

Year:  2007        PMID: 17488391     DOI: 10.1111/j.1399-0012.2007.00658.x

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  6 in total

Review 1.  Depression in Cardiovascular Patients in Middle Eastern Populations: A Literature Review.

Authors:  Tam Truong Donnelly; Jassim Mohd Al Suwaidi; Awad Al-Qahtani; Nidal Asaad; Najlaa Abdul Qader; Rajvir Singh; Tak Shing Fung; Irem Mueed; Shima Sharara; Noha El Banna; Sarah Omar
Journal:  J Immigr Minor Health       Date:  2015-08

Review 2.  Exercise after heart transplantation: An overview.

Authors:  Kari Nytrøen; Lars Gullestad
Journal:  World J Transplant       Date:  2013-12-24

3.  Ischemic time as a predictor of physical recovery in the first months after heart transplantation.

Authors:  Francisco Buendía-Fuentes; Luis Almenar-Bonet; Luis Martínez-Dolz; Ignacio Sánchez-Lázaro; María Rodríguez-Serrano; Diana Domingo-Valero; María José Sancho-Tello de Carranza; Antonio Salvador-Sanz
Journal:  ISRN Cardiol       Date:  2012-06-18

4.  Improvements in exercise capacity following cardiac transplantation in a patient born with double inlet left ventricle.

Authors:  Steve Selig; Steve Foulkes; Mark Haykowsky
Journal:  BMJ Case Rep       Date:  2018-02-05

Review 5.  Importance of physical capacity and the effects of exercise in heart transplant recipients.

Authors:  Marianne Yardley; Lars Gullestad; Kari Nytrøen
Journal:  World J Transplant       Date:  2018-02-24

Review 6.  A Systematic Review and Meta-Analysis of the Effectiveness of High-Intensity Interval Training in People with Cardiovascular Disease at Improving Depression and Anxiety.

Authors:  Tingting Gu; Pengli Hao; Ping Chen; Yi Wu
Journal:  Evid Based Complement Alternat Med       Date:  2022-10-06       Impact factor: 2.650

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.